The company did a fine job of boosting sales of numerous drugs.A double beat in its latest quarter made Johnson & Johnson (JNJ 3.69%) stock a popular item on Wednesday. The encouraging (if not spectacular) results pushed the storied healthcare company's share price up by almost 4%, which contrasted positively with the 1.4% slide of the S&P 500 index on the day.Solid growth, particularly in the No. 1 categoryJohnson & Johnson revealed that its second-quarter sales came in at slightly over $22.4 billion, repr ...